United States

Vitrolife AB (VITR.ST)

VITR.ST on Stockholm Stock Exchange

26 Sep 2016
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for VITR.ST


Vitrolife AB is a Sweden-based company engaged in the development, manufacturing and marketing of instruments and systems for the preparation, cultivation and preservation of human cells, tissues and organs. As of October 1, 2012, it was active within the Fertility segment, which supports fertility clinics with a line of in... (more)


Beta: 0.72
Market Cap(Mil.): kr11,680.04
Shares Outstanding(Mil.): 21.71
Dividend: 2.40
Yield (%): 0.45


  VITR.ST Industry Sector
P/E (TTM): 59.63 37.54 36.60
EPS (TTM): 9.02 -- --
ROI: 21.33 12.49 13.91
ROE: 24.05 14.81 14.82

BRIEF-Vitrolife Q2 core profit rises, market outlook unchanged

* Q2 operating income before depreciation and amortisation (ebitda) amounted to sek 74 (62) million, corresponding to a margin of 35 (34) percent.

Jul 15 2016

BRIEF-Vitrolife Q1 operating profit rises

* Q1 operating income before depreciation and amortization (EBITDA) amounted to SEK 62 (54) million, corresponding to a margin of 33 (33) percent Source text for Eikon: Further company coverage: (Reporting by Oskar von Bahr)

Apr 26 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Wright Reports
Provider : Reuters Investment Profile
Provider : Sadif Analytics Prime
Provider : Sadif Analytics Prime
Provider : GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.